Kansas Governor Vetoes Medicaid Expansion
While Kansas’ GOP-controlled state legislature voted to expand Medicaid, Governor Sam Brownback vetoed the bill. According to The Wall Street Journal, the veto was expected and lawmakers plan to override it. To do so, supporters of expansion would need 27 votes in the state Senate and 84 votes in the state House. Meanwhile, in Arkansas, lawmakers voted to keep the state’s hybrid expansion program. In May, state lawmakers will consider the governor’s proposal to move 60,000 people off Medicaid expansion and into the marketplace and impose work requirements on some expansion participants.
No More Opioids for Pain Treatment
As opioid addiction continues to ruin lives, doctors are increasingly turning to alternative treatment options for chronic pain. Primary care physicians are also looking to non-pharmacologic options, such as acupuncture and physical therapy, for patients seeking treatment for back pain, migraines, and other chronic pain issues, reported California Healthline. Physicians are becoming wary of prescribing opioids and treating chronic pain, which is making it more difficult for patients in pain to get help.
Analyst Predicts Anthem Will Leave ACA Market
June 21, 2017, marks the day when insurers will have to decide if they are staying in the Affordable Care Act (ACA) insurance exchanges for 2018. With Aetna and UnitedHealth already scaling back operations and Humana withdrawing completely, Anthem is considering exiting most ACA exchanges, reported The Washington Post. Anthem currently sells in 14 states and covers 839,000 members through the ACA exchanges.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More